Connect with us

Industry

Guernsey confirms multiple applicants for high-THC cannabis cultivation licences

Seven applications for high-THC cannabis cultivation licences have been made on the island

Published

on

Guernsey cannabis
The state signed a Memorandum of Understanding (MoU) with the UK Home Office relating to cannabis in July.

Seven applications for high-THC cannabis cultivation licences have been made on the island of Guernsey, following a change in legislation earlier this year.

The State of Guernsey signed a Memorandum of Understanding (MoU) with the UK Home Office relating to cannabis in July.

For the first time, the MoU enabled businesses to apply to cultivate high-THC cannabis for medical use.

Previously only licences to cultivate cannabis for CBD products were available. 

The Guernsey Government has now confirmed that it has received seven applications in the last two months.

It added that most of the applications received aim to produce cannabis-based medicinal products.

Deputy Al Brouard, president of the Committee for Health & Social Care, said: “The new cannabis licensing system has been welcomed by the industry and I’m pleased to see that the changes the Health and Social Care team have implemented have already attracted seven applications. Each will now be thoroughly assessed by the BGCA alongside the Home Office and I look forward to seeing the first licences issued to those that are successful.”

Deputy Neil Inder, president of the Committee for Economic Development, added: “It is highly encouraging to see such a positive response from businesses in just a few months since the MoU was signed. These are the early steps of a promising new sector for the Bailiwick, one which is already attracting interest and investment locally and from overseas. Guernsey is now well placed to remain at the forefront of the cannabis industry, and we will continue to support its development.”

Read more industry stories at Cannabis Wealth

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.